11-106010469-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032424.3(MSANTD4):c.449C>T(p.Pro150Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000422 in 1,612,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032424.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSANTD4 | ENST00000301919.9 | c.449C>T | p.Pro150Leu | missense_variant | Exon 2 of 3 | 1 | NM_032424.3 | ENSP00000304713.4 | ||
MSANTD4 | ENST00000530788.1 | c.449C>T | p.Pro150Leu | missense_variant | Exon 2 of 3 | 1 | ENSP00000435125.1 | |||
MSANTD4 | ENST00000534458.1 | c.*116C>T | downstream_gene_variant | 4 | ENSP00000432245.1 | |||||
MSANTD4 | ENST00000530108.1 | c.*234C>T | downstream_gene_variant | 2 | ENSP00000435372.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250394Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135332
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1460724Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 726610
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.449C>T (p.P150L) alteration is located in exon 2 (coding exon 1) of the MSANTD4 gene. This alteration results from a C to T substitution at nucleotide position 449, causing the proline (P) at amino acid position 150 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at